Symbols

REGN

Regeneron·NASDAQ

--(--)

REGN Filings

2026-03-03 · Ownership

Form 4 - Statement of changes in beneficial ownership of securities

2026-02-23 · Ownership

Form 4 - Statement of changes in beneficial ownership of securities

2026-02-19 · Ownership

Form 144 - Report of proposed sale of securities

2026-02-11 · Ownership

Form 4 - Statement of changes in beneficial ownership of securities

2026-02-11 · Ownership

Form 4 - Statement of changes in beneficial ownership of securities

2026-02-09 · Ownership

Form 144 - Report of proposed sale of securities

2026-02-09 · Ownership

Form 144 - Report of proposed sale of securities

2026-02-06 · Ownership

Form 13F-HR - Quarterly report filed by institutional managers, Holdings

2026-02-04 · Financials

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

2026-01-30 · Earnings Call

Regeneron Pharmaceuticals, Inc. (REGN) Q4 2025 Earnings Call Transcript